News

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...
Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...
GSK’s Blenrep is the only B-cell maturation antigen (BCMA)-targeted antibody-drug conjugate for multiple myeloma, offering ...
Support grows for a new test designed to monitor individuals at risk of multiple myeloma, aiming for earlier detection and ...
Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.
For Townsville couple Darryl and Lauren Bailey, a detection machine would have meant Ms Bailey’s rare form of bone marrow ...
A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...
Legend Biotech (LEGN) shares jumped 5% over the past week on heavy trading volume as investors responded to impressive ...
India Bone Marrow Transplantation Market Size Expands at Steady CAGR 4.76% to Touch USD 1.3 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...